Sorrento to Provide Corporate Update, Including DAR-T Cell Therapy Advances, at LEERINK Global Healthcare Conference

    NEXT STORY
    Clinical Trial Supplies Market, Forecast to 2025 – Patent Expirations & Emerging Markets Present Lucrative Opportunities
    PREV STORY
    Global Single-cell Analysis Market (2019 to 2025) – Integration of Microfluidics in Single-cell Analysis Presents Opportunities
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE “TRANSPARENCY LAW”)

    REGULATED INFORMATION GHENT, Belgium, 26 March 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] ...

    author_avatar
    NASDAQ Market News

    Delcath Announces 100th Commercial CHEMOSAT Treatment Completed at Leiden University Medical Center, The Netherlands

    NEW YORK, July 09, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional ...

    author_avatar
    NASDAQ Market News

    FIT Biotech Oy: FIT Biotech Oy converts Convertible Capital Notes into shares and exceeds the authorization granted in the Extraordinary General Meeting on February 6, 2018

    FIT Biotech Oy Company release March 21, 2018 at 03:30 PM EET FIT Biotech ...

    author_avatar
    NASDAQ Market News